Current perspectives of electrical remodeling and its therapeutic implications

被引:14
作者
Wasson, S [1 ]
Reddy, HK [1 ]
Dohrmann, ML [1 ]
机构
[1] Univ Missouri Hosp, Div Cardiol, Columbia, MO 65212 USA
关键词
electrical remodeling; structural remodeling; hypertropthy; ischemia; atrial fibrillation;
D O I
10.1177/107424840400900208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Electrical remodeling involves alterations in the electrophysiologic milieu of myocardium in various disease states, such as ventricular hypertrophy, heart failure, atrial tachyarrhythmias. myocardial ischemia, and infarction that are associated with cardiac arrhythmias. Although research in this area dates back to early part of the 19th century, we still lack the exact knowledge of ionic remodeling, the role of various genes and channel proteins, and their relevance for the newer antiarrhythmic therapies. Structural remodeling may also have an impact on the electrical remodeling process, although differences in both structural and electrical remodeling are associated with different disease states. Various electrophysiologic, cellular, and structural alterations, including anisotropic conduction, increased intracellular calcium levels, and gap junction remodeling predispose to increased dispersion of action potential duration and refractoriness. This constitutes a favorable substrate for early and late afterdepolarizations and reentrant arrhythmias. Studying the role of ionic remodeling in the initiation and propagation of cardiac arrhythmias has significant relevance for developing newer antiarrhythmic therapies, for identifying patients at risk of developing fatal arrhythmias, and for implementing effective preventive measures. Further research is required to understand the specific effects of individual ion channel remodeling, to understand the signal transduction mechanisms, and to address whether detrimental effects of electrical remodeling can be altered.
引用
收藏
页码:129 / 144
页数:16
相关论文
共 128 条
[21]  
Choy AM, 1996, CIRCULATION, V94, pI
[22]   EFFECT OF VASODILATOR THERAPY ON MORTALITY IN CHRONIC CONGESTIVE-HEART-FAILURE - RESULTS OF A VETERANS-ADMINISTRATION COOPERATIVE STUDY [J].
COHN, JN ;
ARCHIBALD, DG ;
ZIESCHE, S ;
FRANCIOSA, JA ;
HARSTON, WE ;
TRISTANI, FE ;
DUNKMAN, WB ;
JACOBS, W ;
FRANCIS, GS ;
FLOHR, KH ;
GOLDMAN, S ;
COBB, FR ;
SHAH, PM ;
SAUNDERS, R ;
FLETCHER, RD ;
LOEB, HS ;
HUGHES, VC ;
BAKER, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (24) :1547-1552
[23]  
Cooklin M, 1997, CIRC RES, V80, P765
[24]   QT dispersion is reduced after valve replacement in patients with aortic stenosis [J].
Darbar, D ;
Cherry, CJ ;
Kerins, DM .
HEART, 1999, 82 (01) :15-18
[25]   Functional and structural assessment of intercellular communication - Increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes [J].
Darrow, BJ ;
Fast, VG ;
Kleber, AG ;
Beyer, EC ;
Saffitz, JE .
CIRCULATION RESEARCH, 1996, 79 (02) :174-183
[26]   SLOW CONDUCTION IN THE INFARCTED HUMAN HEART - ZIGZAG COURSE OF ACTIVATION [J].
DEBAKKER, JMT ;
VANCAPELLE, FJL ;
JANSE, MJ ;
TASSERON, S ;
VERMEULEN, JT ;
DEJONGE, N ;
LAHPOR, JR .
CIRCULATION, 1993, 88 (03) :915-926
[27]   Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation [J].
Dobrev, D ;
Wettwer, E ;
Kortner, A ;
Knaut, M ;
Schüler, S ;
Ravens, U .
CARDIOVASCULAR RESEARCH, 2002, 54 (02) :397-404
[28]   Molecular basis of downregulation of G-protein-coupled inward rectifying K+ current (IK,ACh) in chronic human atrial fibrillation -: Decrease in GIRK4 mRNA correlates with reduced IK,ACh and muscarinic receptor-mediated shortening of action potentials [J].
Dobrev, D ;
Graf, E ;
Wettwer, E ;
Himmel, HM ;
Hála, O ;
Doerfel, C ;
Christ, T ;
Schüler, S ;
Ravens, U .
CIRCULATION, 2001, 104 (21) :2551-2557
[29]   ELECTROPHYSIOLOGIC CHARACTERISTICS OF CELLS SPANNING THE LEFT-VENTRICULAR WALL OF HUMAN HEART - EVIDENCE FOR PRESENCE OF M-CELLS [J].
DROUIN, E ;
CHARPENTIER, F ;
GAUTHIER, C ;
LAURENT, K ;
LEMAREC, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (01) :185-192
[30]   The T-Type Ca2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs [J].
Fareh, S ;
Bénardeau, A ;
Thibault, B ;
Nattel, S .
CIRCULATION, 1999, 100 (21) :2191-2197